Xcelerate IncOTCQB:XCRT
- LAST PRICE0.0229
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0229
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XCRT |
|---|---|---|
| 02:34 ET | 500 | 0.02145 |
| 02:38 ET | 1000 | 0.021015 |
| 02:43 ET | 2000 | 0.02203 |
| 03:01 ET | 1000 | 0.0229 |
Oct 31, 2024
Xcelerate, Inc. Announces Funding, from 8:53AM ET on Thursday Oct 31, 2024 by Dow Jones
8:53AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 23, 2024
Xcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign, from 8:35AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:35AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xcelerate Inc | 9.9M | -16.7x | --- |
Pacific Health Care Organization Inc | 10.5M | 12.1x | -10.80% |
Healthlynked Corp | 9.1M | -1.5x | --- |
Univec Inc | 7.9M | --- | --- |
Kindly MD Inc | 5.8M | -1.8x | --- |
Burning Rock Biotech Ltd | 55.2M | -0.1x | --- |
Company Information
Xcelerate, Inc. seeks to acquire technology/healthcare business. The Company’s business plan encompasses three separate but related businesses within the medical, health and wellness sectors, including owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses; formulation, packaging and marketing of over the counter, clinically tested skin care products, and development of virtual health technology to assist patients in developing countries, initially in Africa, to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.
Contact Information
- Headquarters
- 110 Renaissance CircleMAULDIN, SC, United States 29662
- Phone
- 954-575-2252
- Fax
- ---
Executives
- Chief Executive Officer, Director
- Michael O'Shea
- Chief Scientific Officer
- Anja Glisovic
- Director
- Steve Gravely
- Director
- Jon Wilken
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.9M |
|---|---|
Revenue (TTM) | $4.0M |
Shares Outstanding | 432.4M |
Xcelerate Inc does not pay a dividend. | |
Beta | 3.16 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -16.7x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
